METABOLISMO ÓSEO, VASCULAR, ENFERMEDADES INFLAMATORIAS CRÓNICAS Y BIOMARCADORES
METOSEO
Hospital Virgen del Camino
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (10)
2021
-
The impact of age on mortality in chronic haemodialysis popu-lation with covid-19
Journal of Clinical Medicine, Vol. 10, Núm. 14
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
2019
-
Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort
Frontiers in Genetics, Vol. 10, Núm. FEB
2018
-
Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)
Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129
2017
-
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520
2016
-
A comprehensive fracture prevention strategy in older adults: The European union geriatric medicine society (EUGMS) statement
European Geriatric Medicine, Vol. 7, Núm. 6, pp. 519-525
2015
-
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185
2007
-
Estudio nacional de vigilancia de infección nosocomial en unidades de cuidados intensivos. Informe evolutivo de los años 2003-2005
Medicina Intensiva, Vol. 31, Núm. 1, pp. 6-17
2006
-
Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial
Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326
2003
-
Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage
Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481